US Stock MarketDetailed Quotes

Avenue Therapeutics (ATXI)

Watchlist
  • 0.7690
  • -0.0310-3.88%
15min DelayClose Dec 5 15:34 ET
1.58MMarket Cap-0.07P/E (TTM)

About Avenue Therapeutics Company

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Company Profile

SymbolATXI
Company NameAvenue Therapeutics
Listing DateJun 27, 2017
Issue Price6.00
ISINUS05360L4032
Founded2015
CEODr. Alexandra MacLean, M.D.
MarketPink Market
Employees2
Fiscal Year Ends12-31
Address1111 Kane Concourse,Suite 301
CityBay Harbor Islands
ProvinceFlorida
CountryUnited States of America
Zip Code33154
Phone1-781-652-4500

Company Executives

  • Name
  • Position
  • Salary
  • Alexandra MacLean
  • Chief Executive Officer and Director
  • --
  • David Jin
  • Interim Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
  • --
  • Jay Kranzler
  • Chairman of the Board
  • --
  • Lindsay A. Rosenwald
  • Director
  • --
  • Neil Herskowitz
  • Independent Director
  • --
  • Faith Charles
  • Independent Director
  • --
  • Curtis Oltmans
  • Independent Director
  • --
Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More